MapLight Therapeutics, Inc. (MPLT) SEC filings
MPLT SEC filings moved a median of +2.97% by the close. MPLT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MPLT overview →
25 measured MPLT SEC filing events.
Where these MPLT SEC filings landedvs 25 measured MPLT SEC filing reactions
| Middle 50% of MPLT SEC filing reactions | -1.45% to +6.47% |
|---|---|
| Median reaction (to close) | +2.97% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 MPLT SEC filing events with a measured close landed between -1.45% and +6.47%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT MapLight Therapeutics, | SEC filing · Form EFFECT | -1.65% | +1.51% | |
| Form S-1/A MapLight Therapeutics, | SEC filing · Form S-1 | -1.49% | -1.45% | |
| Form S-1 MapLight Therapeutics, | SEC filing · Form S-1 | -1.04% | +2.19% | |
| Form 10-Q MapLight Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.58% | -2.41% | |
| Form 8-K MapLight Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -0.58% | -2.41% | |
| Form 8-K MapLight Therapeutics, For: Jul 27 | SEC filing · Form 8-K | -9.09% | -23.69% | |
| Form 8-K MapLight Therapeutics, For: Jun 23 | SEC filing · Form 8-K | +1.82% | +7.13% | |
| Form 8-K MapLight Therapeutics, For: Jun 22 | SEC filing · Form 8-K | +7.52% | +6.47% | |
| Form 8-K MapLight Therapeutics, For: Jun 18 | SEC filing · Form 8-K | +7.52% | +6.47% | |
| Form 10-Q MapLight Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.95% | |
| Form 8-K MapLight Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.00% | +0.95% | |
| Form 8-K MapLight Therapeutics, For: Apr 23 | SEC filing · Form 8-K | -0.91% | +5.29% | |
| Form ARS MapLight Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.91% | +5.29% | |
| Form DEF 14A MapLight Therapeutics, For: Jun 23 | SEC filing · Form DEF | -0.91% | +5.29% | |
| Form DEFA14A MapLight Therapeutics, | SEC filing · Form DEFA14A | -0.91% | +5.29% | |
| Form 10-K MapLight Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +9.14% | |
| Form 8-K MapLight Therapeutics, For: Mar 26 | SEC filing · Form 8-K | +0.00% | +9.14% | |
| Form S-8 MapLight Therapeutics, | SEC filing · Form S-8 | +0.00% | +9.14% | |
| Form 8-K MapLight Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -0.34% | +2.97% | |
| Form 10-Q MapLight Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.24% | +11.42% | |
| Form 8-K MapLight Therapeutics, For: Dec 04 | SEC filing · Form 8-K | +0.24% | +11.42% | |
| Form 8-K MapLight Therapeutics, For: Oct 26 | SEC filing · Form 8-K | +0.36% | -1.31% | |
| Form S-8 MapLight Therapeutics, | SEC filing · Form S-8 | +0.05% | -3.47% | |
| Form 8-A12B MapLight Therapeutics, | SEC filing · Form 8-A12B | +0.05% | -3.47% | |
| Form CERT MapLight Therapeutics, | SEC filing · Form CERT | +0.05% | -3.47% |
Keep exploring
More MPLT: earnings → · analyst actions → · MPLT overview →